Klinefelter's Syndrome
Summary
Klinefelter's syndrome (KS) is the most common sex chromosome aneuploidy in males, with a karyotype of 47,XXY (one extra X chromosome). It is the most common genetic cause of male infertility and hypogonadism. Most cases are undiagnosed until adulthood, often presenting with infertility. Clinical features include tall stature, small firm testes, gynaecomastia, sparse body hair, and learning difficulties. Biochemically, there is hypergonadotrophic hypogonadism (high LH/FSH, low testosterone). Treatment involves testosterone replacement therapy (TRT) to improve secondary sexual characteristics, bone density, and quality of life. Fertility may be possible with testicular sperm extraction (TESE) and ICSI.
Key Facts
- Karyotype: 47,XXY (extra X chromosome)
- Incidence: 1 in 500-1000 male births
- Classic Features: Tall stature, small testes, gynaecomastia, sparse facial hair
- Biochemistry: High LH/FSH (hypergonadotrophic), Low testosterone
- Treatment: Testosterone replacement therapy
- Fertility: Usually infertile; TESE + ICSI may work
Clinical Pearls
"Most Are Undiagnosed": Only 25% of Klinefelter cases are diagnosed, often only when presenting with infertility in adulthood.
"High Gonadotrophins, Low Testosterone": The testes fail (primary hypogonadism), so LH and FSH are high as the pituitary tries to stimulate them. Testosterone remains low.
"Tall with Small Testes": The combination of tall stature with small, firm testes is classic for Klinefelter's.
"Testosterone Helps, But Not Fertility": TRT improves sexual function, bone density, and quality of life, but does NOT restore fertility. Sperm extraction may be possible.
Incidence
- 1 in 500-1000 live male births
- Most common sex chromosome aneuploidy
- Most common genetic cause of male infertility
Diagnosis
- Only ~25% diagnosed (most are mild)
- Median age at diagnosis: 27 years (often with infertility)
- Increasing prenatal detection with NIPT
Variants
| Karyotype | Frequency | Phenotype |
|---|---|---|
| 47,XXY | 80-90% | Classic Klinefelter |
| 48,XXXY | Rare | More severe learning difficulties |
| 49,XXXXY | Very rare | Severe intellectual disability, more dysmorphism |
| 46,XY/47,XXY (mosaic) | 10% | Milder phenotype |
Genetic Mechanism
- Non-disjunction during meiosis (maternal ~60%, paternal ~40%)
- Extra X chromosome → Testicular dysgenesis → Hypogonadism
Why Hypogonadism?
- Testicular degeneration begins in utero
- Accelerated germ cell and Leydig cell loss at puberty
- By adulthood: Small, fibrotic testes with absent spermatogenesis
Hormone Profile
| Hormone | Level | Explanation |
|---|---|---|
| Testosterone | Low | Testicular failure |
| LH | High | Pituitary compensation |
| FSH | High | Pituitary compensation |
| Inhibin B | Low | No Sertoli cell function |
| Oestradiol | May be high-normal | Aromatisation of testosterone |
By Age
| Stage | Features |
|---|---|
| Infancy | Usually undetected; may have small phallus, cryptorchidism |
| Childhood | Learning difficulties, speech delay, behavioural issues |
| Puberty | Delayed/incomplete puberty, gynaecomastia |
| Adulthood | Infertility, small testes, tall stature, sparse body hair |
Classic Adult Features
| Feature | Notes |
|---|---|
| Tall stature | Due to delayed epiphyseal closure (low testosterone) |
| Small, firm testes | <4mL (typically pea-sized); fibrotic |
| Gynaecomastia | Breast tissue development (oestrogen effect) |
| Sparse body/facial hair | Reduced androgens |
| Female fat distribution | Hips, buttocks |
| Infertility | Azoospermia (most common presentation) |
Associated Conditions
General
- Tall stature (arm span > height in some)
- Eunuchoid proportions (long limbs relative to trunk)
Secondary Sexual Characteristics
- Sparse facial and body hair
- Gynaecomastia (palpate for breast tissue)
- Female-pattern fat distribution
Genitalia
- Small, firm testes (<4mL bilaterally)
- Normal or small phallus
Other
- May have mild intellectual difficulties
First-Line
| Test | Finding |
|---|---|
| Karyotype | 47,XXY (confirms diagnosis) |
| Testosterone | Low |
| LH | High |
| FSH | High |
| Semen analysis | Azoospermia (usually) |
Additional
| Test | Purpose |
|---|---|
| Oestradiol | May be elevated (gynaecomastia) |
| Inhibin B | Low (Sertoli cell failure) |
| DEXA scan | Assess bone density (osteoporosis risk) |
| Fasting glucose/lipids | Metabolic syndrome screening |
| Breast exam | Cancer risk |
Testosterone Replacement Therapy
┌──────────────────────────────────────────────────────────┐
│ KLINEFELTER'S SYNDROME MANAGEMENT │
├──────────────────────────────────────────────────────────┤
│ │
│ TESTOSTERONE REPLACEMENT: │
│ • Start at puberty if testosterone low │
│ • Options: │
│ - IM testosterone (Sustanon/Nebido) │
│ - Transdermal gel │
│ - Oral testosterone undecanoate │
│ • Benefits: │
│ - Secondary sexual characteristics │
│ - Bone density │
│ - Muscle mass and energy │
│ - Mood and quality of life │
│ • Does NOT restore fertility │
│ │
│ FERTILITY: │
│ • Testicular sperm extraction (TESE) │
│ • ICSI (Intracytoplasmic sperm injection) │
│ • Success rate variable (sperm found in ~50%) │
│ • Best if attempted early (before severe atrophy) │
│ │
│ MONITORING: │
│ • Regular testosterone levels │
│ • Haematocrit (polycythaemia risk with TRT) │
│ • DEXA scan (bone density) │
│ • Breast examination (cancer risk) │
│ • Metabolic profile │
│ │
│ MDT INVOLVEMENT: │
│ • Endocrinology │
│ • Urology/Reproductive medicine │
│ • Psychology/Educational support │
│ │
└──────────────────────────────────────────────────────────┘
Of Klinefelter's Syndrome
- Infertility
- Osteoporosis
- Breast cancer (20x risk of male pop)
- Metabolic syndrome / T2DM
- Autoimmune disease
- Venous thromboembolism
- Learning difficulties
- Psychological impact
Of Treatment
- Polycythaemia (with TRT)
- Acne, mood changes (TRT)
- Prostate risk (theoretical with TRT)
With Treatment
- Normal life expectancy (slightly reduced in some studies)
- Good quality of life with TRT
- Fertility possible in some with TESE/ICSI
Without Treatment
- Osteoporosis
- Metabolic complications
- Psychological issues
Key Guidelines
- Endocrine Society Clinical Practice Guideline: Klinefelter Syndrome
- European Academy of Andrology Guidelines
Key Evidence
TRT
- Improves bone density, body composition, and quality of life
Fertility
- TESE successful in ~50% of XXY males
- Better outcomes with earlier intervention
What is Klinefelter's Syndrome?
Klinefelter's syndrome is a condition where males are born with an extra X chromosome (XXY instead of XY). It affects about 1 in 600 boys.
What Are the Signs?
- Taller than average
- Smaller testicles
- Breast tissue (gynaecomastia)
- Less facial and body hair than usual
- Difficulty having children (infertility)
- May have learning difficulties
Is There Treatment?
Yes:
- Testosterone treatment can help with energy, muscle mass, bone strength, and sexual development
- Fertility treatment (sperm extraction and IVF) may allow some men with Klinefelter's to have biological children
What About School and Work?
Many people with Klinefelter's live completely normal lives. Some may need extra help at school, particularly with language and reading. With support, most do very well.
Primary Guidelines
- Endocrine Society. Testosterone Therapy in Men with Hypogonadism. J Clin Endocrinol Metab. 2018.
Key Studies
- Lanfranco F, et al. Klinefelter's syndrome. Lancet. 2004;364(9430):273-283. PMID: 15262102